Amo Pharma Limited
- Active
- Small
- 11 years
- 0 employees
- £2,073,726 (cur assets)
- 1m-15m
- Virtual address
- 5 directors
- 1 owner
- Leeds
Two conditions of three:
1.Turnover < £10.2 million
2.Balance sheet total < £5.1 million
3.Average number of employees < 50
Field of Operation
Summary
Amo Pharma Limited is a private limited company registered in England/Wales with the registration number 09431909. The company was founded eleven years ago on February 10, 2015, and registered at LS1 5AB, England, Leeds, 1 Park Row. The address is probably virtual as 215 companies are registered at the same address. Its status is active. The company operates in the professional services, the scientific and technical r&d industries. Officially, it has one owner or PSCs, five directors, and zero employees.
It's a small company as it met two conditions of three: turnover less than £10.2 million, balance sheet less than £5.1 million, employees less than 50. The last reported current assets is £2,073,726.
WARNING: The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.
Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.
Owners & PSC
-
Individual
- 6 years
- 8
- psc
-
Resident of Switzerland
Managers
-
Individual
- 2 years
- 1
-
Resident of Ireland
-
Individual
- 2 years
-
Resident of United States
-
Individual
- 4 years
- 1
-
Resident of United States
-
Individual
- 10 years
-
Resident of United States
-
Individual
- 11 years
- 3
-
Resident of United Kingdom
Last reports
The latest confirmation statement submitted four months ago.
Last news
-
Total exemption full accounts made up to 2025-12-31Download 15 pages pdf report
-
Registration of charge 094319090004, created on 2026-05-20Download 44 pages pdf report
-
Confirmation statement made on 2026-02-10 with updatesDownload 7 pages pdf report
FAQ about Amo Pharma Limited
Looking for leads in the UK?
Book a demo—see how CorpSignals can help you find UK leads.